Migraine

Headache
We are now accepting participants for a Migraine clinical study to evaluate the efficacy and safety profiles of ABP-450 administered at 150 units and 195 units compared to placebo in patients with migraine.
No insurance is required.
Earn Compensation 
  • We have many clinical studies available and many more coming in the future so please let us know what study may interest you.
landing-page-how-it-works

EARN COMPENSATION 

dry-eye-landing-page-contact
DCT-logo-studies-page